biotech

Expensive laboratory tests
Manufacturing

Ansa snares $54.4M in series B to boost its DNA synthesis tech

Ansa Biotechnologies hauled in $54.4 million in a series B financing round that will be used to expand DNA synthesis capacity.
Joseph Keenan Oct 2, 2025 8:50am
white hawk bird flying

Aadi takes flight with new moniker: Whitehawk Therapeutics

Mar 18, 2025 4:45pm
A compass pointing at brand on the dial

Biotech rebrands as Octavian, plans recovery from past setbacks

Feb 11, 2025 11:30am
nametags naming branding

Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics

Jan 7, 2025 3:20pm
Takeda

Takeda joins growing list of drugmakers to leave trade group BIO

Apr 26, 2024 7:25am
Microphone

Belharra shares short history in 'Birth of a Biotech Podcast'

Feb 29, 2024 10:22am